Pharmaceutical manufacturer Aspen Pharmacare will buy the Latin American commercial rights and intellectual property for a portfolio of Viatris’ branded products including the erectile dysfunction drug Viagra, in a deal worth $280m (about R5bn).

Aspen’s Latin American business delivers more than a tenth of the company’s turnover, and the region offers strong growth opportunities, said Aspen CEO Stephen Saad...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.